Inventor · disambiguated record
Shinsaku Nakagawa
Also filed as: NAKAGAWA SHINSAKU
8 granted patents·5 pending applications·65 citations·filing 1997–2022
83Inventor score
Files withHAYASHIBARA BIOCHEM LAB4CHUGAI PHARMACEUTICAL CO LTD3UNIV OSAKA2COSMED PHARMACEUTICAL CO LTD1FUSO PHARMACEUTICAL IND1
Top patents by PatentIndex Score
13 records- 0193US7993636B2Tumor necrosis factor-alpha mutantsHAYASHIBARA BIOCHEM LAB·Filed 2005·Granted Aug 9, 2011·36 cites·9 claims
- 0279US7989588B2Cell permeable peptideUNIV OSAKA·Filed 2006·Granted Aug 2, 2011·3 cites·5 claims
- 0378US7179891B2Physiologically active complexHAYASHIBARA BIOCHEM LAB·Filed 2003·Granted Feb 20, 2007·9 cites·5 claims
- 0468US6875448B1Method of intracellular sustained-release of drug and preparationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2000·Granted Apr 5, 2005·16 cites·9 claims
- 0559US2010136092A1Transdermal immune preparation, method for production of the same, and transdermal immunization method using the sameNAKAGAWA SHINSAKU·Filed 2008·Application pending·0 cites
- 0657US2006258005A1Novel virus vectorFUSO PHARMACEUTICAL IND·Filed 2004·Application pending·0 cites
- 0756US2025120942A1Brain function improving agentUNIV OSAKA·Filed 2022·Application pending·0 cites
- 0853US7189824B2Tumor vessel endothelial cell-binding monoclonal antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Mar 13, 2007·0 cites·17 claims
- 0950US7666403B2Mutant interferon α protein and use thereofHAYASHIBARA BIOCHEM LAB·Filed 2005·Granted Feb 23, 2010·0 cites·6 claims
- 1048US2015290163A1Retinoic acid microneedleCOSMED PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1146US2004001802A1Physiologically active complexHAYASHIBARA BIOCHEM LAB·Filed 2003·Application pending·0 cites
- 1244US8187584B2Human tumor necrosis factor-α mutantsMAYUMI TADANORI·Filed 2011·Granted May 29, 2012·0 cites·2 claims
- 1330US6440733B1Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vesselCHUGAI PHARMACEUTICAL CO LTD·Filed 1997·Granted Aug 27, 2002·1 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →